The First mRNA Flu Vaccine for Older Adults Has Been Approved in the US. How Does It Differ From the Traditional Vaccine?
8 Articles
8 Articles
By Elise Haulund, CNN For older adults, the flu vaccine could be somewhat different this year.Last week, the U.S. Food and Drug Administration (FDA) approved the country's first mRNA-based flu vaccine for use in 50-year-olds The post The first MRNA flu vaccine for older adults is approved in the U.S. How does it differ from the traditional one? appeared first on KVIA.
Moderna Secures U.S. mRNA Flu Vaccine Approval, Revenue Gains Not Expected Before 2027
CAMBRIDGE, Massachusetts, August 14, 2026, 10:53 EDT — Moderna Inc. (NASDAQ:MRNA) secured regulatory clearance for its pioneering mRNA-based flu vaccine in the United States, but analysts expect the new product will not make a significant impact on revenue until late 2027, positioning the breakthrough as a challenge for the company’s cash management. The split is…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
